ARTICLE AD BOX
Researchers at Duke-NUS Medical School have discovered a molecular "switch" that determines whether pancreatic cancer cells respond to chemotherapy or resist it. The finding points to a way to potentially shift some of the most treatment resistant tumors into a state where existing drugs can work more effectively.
The study, published in the Journal of Clinical Investigation, explains how this switch operates at a molecular level. The results suggest ...

6 days ago
15







English (US) ·